{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825893953552384.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/j.neuropharm.2006.08.005"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0028390806002693?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0028390806002693?httpAccept=text/plain"}}],"dc:title":[{"@value":"Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: Evidence for synergism between serotonergic and noradrenergic reuptake inhibition"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825893953552387","@type":"Researcher","foaf:name":[{"@value":"Carrie K. Jones"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893953552384","@type":"Researcher","foaf:name":[{"@value":"Brian J. Eastwood"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893953552386","@type":"Researcher","foaf:name":[{"@value":"Anne B. Need"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893953552385","@type":"Researcher","foaf:name":[{"@value":"Harlan E. Shannon"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00283908"}],"prism:publicationName":[{"@value":"Neuropharmacology"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2006-12","prism:volume":"51","prism:number":"7-8","prism:startingPage":"1172","prism:endingPage":"1180"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0028390806002693?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0028390806002693?httpAccept=text/plain"}],"createdAt":"2006-10-12","modifiedAt":"2019-01-12","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360564063954547456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Successful Treatment by Adding Duloxetine to Pregabalin for Peripheral Neuropathy Induced by Paclitaxel"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/j.neuropharm.2006.08.005"},{"@type":"CROSSREF","@value":"10.1177/1049909112463416_references_DOI_9eALb4O0fXk6mpaNd6itBTgHZKL"}]}